MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 184 filers reported holding MYRIAD GENETICS INC in Q3 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $875,000 | -36.8% | 30,097 | 0.0% | 0.99% | -26.3% |
| Q3 2018 | $1,384,000 | +23.0% | 30,097 | 0.0% | 1.35% | +23.6% |
| Q2 2018 | $1,125,000 | +26.5% | 30,097 | 0.0% | 1.09% | +23.8% |
| Q1 2018 | $889,000 | -82.0% | 30,097 | -79.1% | 0.88% | -81.9% |
| Q4 2017 | $4,949,000 | -0.2% | 144,097 | +5.1% | 4.88% | -13.9% |
| Q3 2017 | $4,961,000 | +22.2% | 137,111 | -12.7% | 5.67% | +21.3% |
| Q2 2017 | $4,060,000 | +34.6% | 157,111 | 0.0% | 4.67% | +41.2% |
| Q1 2017 | $3,017,000 | +33.1% | 157,111 | +15.6% | 3.31% | +31.5% |
| Q4 2016 | $2,266,000 | +15.3% | 135,911 | +42.3% | 2.52% | +19.0% |
| Q3 2016 | $1,966,000 | -25.7% | 95,511 | +22.7% | 2.11% | -16.9% |
| Q2 2015 | $2,645,000 | -4.0% | 77,810 | 0.0% | 2.54% | +3.3% |
| Q1 2015 | $2,754,000 | +3.9% | 77,810 | 0.0% | 2.46% | -5.4% |
| Q4 2014 | $2,650,000 | – | 77,810 | – | 2.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 6,459,139 | $278,776,000 | 5.53% |
| Tieton Capital Management, LLC | 119,290 | $5,149,000 | 4.04% |
| RPg Family Wealth Advisory, LLC | 97,202 | $4,195,238,000 | 3.85% |
| RK Capital | 384,900 | $16,612,000 | 2.90% |
| Contrarius Investment Management Ltd | 652,288 | $28,153,000 | 2.65% |
| S&T BANK/PA | 331,885 | $14,324,000 | 2.22% |
| Euclidean Technologies Management, LLC | 40,917 | $1,766,000 | 1.90% |
| AIMZ Investment Advisors, LLC | 45,635 | $1,970,000 | 1.80% |
| Taylor Frigon Capital Management LLC | 34,783 | $1,486,000 | 1.67% |
| KILLEN GROUP INC | 366,305 | $15,810,000 | 1.63% |